Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Cancer research
2018
Correction: Targeting Cyclin D-CDK4/6 Sensitizes Immune-refractory Cancer by Blocking the SCP3-NANOG Axis.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Correction: Targeting Cyclin D-CDK4/6 Sensitizes Immune-refractory Cancer by Blocking the SCP3-NANOG Axis. | OpenQuestion